Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related NLNK
Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Profit Margin
UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone
NewLink Genetics earnings up 222% in Q1 (Seeking Alpha)
Related
Qualys Shares Shatter On Slow Sales; Cybersecurity Names Feeling The Pain
Morgan Stanley On FireEye: 'Go Big Or Go Home'
FireEye: Increasing Dominance In The Cybersecurity Arena (Seeking Alpha)

Analogic (NASDAQ: ALOG) shares dropped 11.20% to $85.75 in pre-market trading after the company reported downbeat Q2 earnings.

NewLink Genetics (NASDAQ: NLNK) shares fell 7.14% to $35.00 in the pre-market trading after the company's independent review committee recommended the study continuation without modification after completion of first interim analysis of IMPRESS Phase 3 pancreatic cancer trial with algenpantucel-L.

FireEye (NASDAQ: FEYE) dipped 6.71% to $83.54 after the company priced its follow-on public offering of 14 million shares at $82.00 per share.

The Gap (NYSE: GPS) dipped 3.64% to $40.75 in the pre-market session after the company reported a 7% drop in its February same-store sales. However, analysts were expecting a 1.1% rise in same-store sales.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (ALOG + FEYE)

Around the Web, We're Loving...